Search results
Jump to navigation
Jump to search
Page title matches
- ...lation Study Based on Biological Effective Dose in Radioimmunotherapy With 90Y-Ibritumomab Tiuxetan (Zevalin). [serial on the Internet]. 2010 Jan. 13 [cited 2010, Oct. 7];13. 10. Ferrucci, P, et. al. High Activity 90Y-Ibritumomab Tiuxetan (Zevalinâ) With Peripheral Blood Progenitor Cells Support in Patients With11 KB (1,563 words) - 03:38, 7 October 2013
- 135 bytes (17 words) - 00:53, 1 November 2010
- 827 bytes (133 words) - 00:53, 1 November 2010
Page text matches
- ...lation Study Based on Biological Effective Dose in Radioimmunotherapy With 90Y-Ibritumomab Tiuxetan (Zevalin). [serial on the Internet]. 2010 Jan. 13 [cited 2010, Oct. 7];13. 10. Ferrucci, P, et. al. High Activity 90Y-Ibritumomab Tiuxetan (Zevalinâ) With Peripheral Blood Progenitor Cells Support in Patients With11 KB (1,563 words) - 03:38, 7 October 2013